CureVac Manufacturing v Moderna (CFI, 14 September 2026)
| Date | 14 September 2026 |
|---|---|
| Court | CFI |
| Division | The Hague (NL) Local Division |
| Type of action | Infringement Action |
| Case number(s) | UPC_CFI_1407/2026 |
| Registry reference | UPC-CFI-0001407/2026 |
| Parties | CureVac Manufacturing GmbH v. Moderna, Inc., Moderna Netherlands B.V., Moderna Switzerland GmbH, Moderna Biotech Spain SL, ModernaTX, Inc., Mo… |
Official decision (PDF) · UPC registry entry
Case timeline
- 1 July 2026 : CureVac Manufacturing v Moderna (CFI, UPC_CFI_1407/2026, 1 July 2026) UPC-CFI-1407/2026
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 11 September 2026, the judge-rapporteur of The Hague Local Division defers Moderna’s preliminary objection on international jurisdiction to the main proceedings, dismisses its Rule 361 request and provisionally grants confidentiality protection limited to the representatives of CureVac Manufacturing GmbH. The order, made in the infringement action on EP 4 108 769, shows that an objection which cannot dispose of the whole action need not be decided at the outset.
Question
Must a preliminary objection directed at certain defendants and at claims concerning non-UPC States be decided immediately, and can those claims be dismissed under Rule 361 RoP?
Decision
Since the objection could lead neither to the dismissal of the whole action for lack of jurisdiction nor to the division lacking competence for the entire case, and since case law in this area is evolving rapidly, the decision is deferred to the main proceedings under Rule 20.2 RoP (paragraph 7). A Rule 361 application, assuming it is admissible within a preliminary objection, is reserved for clear-cut situations. This is not one, and the application is dismissed (paragraph 8). Pending a final order under Rule 262A RoP, the unredacted statement of defence and counterclaim for revocation are available only to CureVac’s representatives and their assistants (paragraphs 9 and 10). The panel also states its intention not to bifurcate under Art. 33(3)(a) UPCA (paragraph 11).
Key points for practice
- A partial preliminary objection on jurisdiction may be deferred to the main proceedings where the relevant case law is still developing (paragraph 7).
- Dismissal under Rule 361 RoP requires a clear-cut situation, in line with the Court of Appeal case law cited in the order (paragraph 8).
Provisions applied
- Agreement on a Unified Patent Court
- Art. 33(3)(a)
- Rules of Procedure
- Rules 19, 20.2, 262.2, 262A and 361
- Case law cited
- Aylo v Dish, Court of Appeal, 3 September 2024, on the admissibility of a Rule 361 application within a preliminary objection, Microsoft v Suinno, Court of Appeal, 15 October 2024, on Rule 361 being reserved for clear-cut situations.
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: Patent infringement action.
Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantCureVac Manufacturing GmbH3 decisions in the corpusFollow this party
- defendantModerna, Inc.3 decisions in the corpusFollow this party
- defendantModerna Netherlands B.V.5 decisions in the corpusFollow this party
- defendantModerna Switzerland GmbH2 decisions in the corpusFollow this party
- defendantModerna Biotech Spain SLFollow this party
- defendantModernaTX, Inc.4 decisions in the corpusFollow this party
- defendantMoFollow this party
Decisions in the same proceedings and documented appeals
- 1 July 2026 CureVac Manufacturing v Moderna (CFI, UPC_CFI_1407/2026, 1 July 2026) Infringement Action · UPC_CFI_1407/2026
La demande de production de preuves, recevable, est rejetée faute de nécessité et de proportionnalité tant que les défenderesses n’ont pas répondu sur la contrefaçon. Les délais convenus sont confirmés.
- 14 September 2026 CureVac Manufacturing v Moderna (CFI, 14 September 2026) Infringement Action · UPC_CFI_1407/2026
What the record states
- Nature of the act
- Infringement Action
- Outcome (Dhenne Avocats summary)
- L’exception préliminaire de Moderna sur la compétence est renvoyée au fond, sa demande fondée sur la règle 361 est rejetée faute de situation manifeste, et la demande de confidentialité est provisoirement accueillie au profit des seuls représentants de CureVac.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 4 108 769mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- CureVac Manufacturing v Moderna (CFI, UPC_CFI_1407/2026, 1 July 2026) cited in this record
- Microsoft v Suinno Mobile & AI Technologies Licensing (CoA, 15 October 2024) cited in this record
- AYLO Premium v DISH Technologies (CoA, 3 September 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 4 108 769 | Mentioned in the analysis (role not qualified) Also mentioned in 1 other decision(s): CureVac Manufacturing v Moderna (CFI, UPC_CFI_1407/2026, 1 July 2026) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.